The Cutting Room: Biotech or Internet?
Him or Jim? YOU decide.
That's the word from Gary B. Smith. He thinks there's just not enough room for two kings at TheStreet.com.
Let It Ride vs. Grab Some Gains Now!During Word on the Street, I asked: How do you protect your profits in this kind of market mania? In one corner, Jim Cramer (doesn't he always seem to be on one side of every debate?). In the other, Graham Tanaka, whose mutual fund is up nearly 30% in the year to date. Cramer's ready answer: Don't be a pig, you'll get slaughtered. Now's the time, he says, to trim some of the big winners in your portfolio. Take some money off the table! Not so fast, Tanaka piped in. He's a buy-and-holder -- rare in these daytrading days -- and has owned Intel (INTC) for more than a decade. Adam Lashinsky, our Silicon Valley correspondent, on whom I depend during this segment as the never-flinching voice of reason, reminds us of a simple rule: You've got to be able to sleep at night. This might be a good opportunity to re-evaluate your tolerance for risk and get out of some of those more volatile stocks that wake you up at 3 a.m.
The Classic: Da Charts vs. Da FundiesYep. Each show, this is one of my favorites. The Chartman takes on Mr. Fundamental, Adam Lashinsky. Chartman claims to know nothing about what a company does, relying only on charts for investment guidance, while Mr. Fundamental is the best in the business at figuring out the nuts and bolts of a company: bottom line, earnings and competitive advantage. They take on the biggest biotech turned biowreck, Aviron (AVIR) (Gary's a bull, Adam bearish), then tackle MicroStrategy (MSTR), the software stock that cratered last week on earnings news ("I'd love to love it," says Gary, but he doesn't like the look of its chart. As for Adam, he's convinced it's a good company that will win out in the long term.)
Buy vs. SellYep, Cramer takes on the stock market. (I know who I'm betting on!) You've got a favorite stock? He's got an opinion (or two or three), giving you the bottom line on stocks you're asking about. This isn't like the typical boring old "buy, sell or hold" segments that fill most business programming. No wimpy "long-term holds" here. Cramer tells it like it is -- and he doesn't mince words. Jim doesn't know which stocks you'll bring up, but he lives this stuff every minute of every day, so you can count on a no-holds-barred response. A couple of examples:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts